Received Jul 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z007214 | — |
HCP reported that the patient did not experience any adverse side effects from administered dose; HCP called to report TE for PROQUAD with a prior excursion on 6/18/2025 and a current excursion on 07/02/2025 that was administered post excursion to a patient on 06/24/2025.; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 24-JUN-2025, the patient was vaccinated with a improper storage Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) Injection (lot #Z007214, expiration date: 05-Oct-2026) at a dose of 0.5 mL reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not reported) for prophylaxis following a temperature excursion of 8.6F for 1 hour, 17 minutes, 0 seconds, and 6.8F for 0 hours, 47 minutes, 0 seconds. HCP reported that the patient did not experience any adverse side effects from administered dose was unknown.
Sterile diluent